3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Recruiting
1
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Polycystic Ovary Syndrome
35
Breast Neoplasms
8
Obesity
5
Neoplasms
5
Prostatic Neoplasms
4
Insulin Resistance
4
Pancreatic Neoplasms
3
Infertility
3
Endometrial Neoplasms
3
Diabetes Mellitus
3
Triple Negative Breast Neoplasms
2
Neuroendocrine Tumors
2
Mouth Neoplasms
2
Metabolic Syndrome
2
Liver Neoplasms
2
Hyperandrogenism
2
Diabetes, Gestational
2
Diabetes Mellitus, Type 2
2
Depression
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Brain Neoplasms
2
Anovulation
2
Weight Loss
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Nodule
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Interventions
Temozolomide
16
Radiotherapy
7
apatinib
5
anlotinib
3
Surgical Procedures, Operative
3
Chlorotoxin
3
Bevacizumab
3
Aminolevulinic Acid
3
Positron Emission Tomography Computed Tomography
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
Lomustine
2
Irinotecan
2
Immunotherapy, Adoptive
2
Blood Specimen Collection
2
vandetanib
1
sodium thiosulfate
1
ribociclib
1
poly ICLC
1
lonafarnib
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
etoposide phosphate
1
Vinblastine
1
Valproic Acid
1
Tranexamic Acid
1
Surveys and Questionnaires
1
Sunitinib
1
Rivaroxaban
1
Radiosurgery
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Glioma
×
Metformin
×
Clear all
NCT02149459
2017-10-27
SMC 0712-13
Sheba Medical Center
Phase 1
Unknown
18 enrolled